جست‌وجوی استاد و پژوهشگر

• Clinical Toxicology
• Pharmacoepidemiology
• Poisoning
• +۳ مورد دیگر

Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.

Wolfgang Wüsterمشاهده پروفایل

استاد

• Evolutionary Biology
• Snake Systematics
• Venom Toxicology
• +۵ مورد دیگر

Professor Wolfgang Wüster is a Professor in Zoology (Molecular Ecology) at Bangor University's School of Environmental and Natural Sciences. His research focuses on evolutionary biology, snake systematics, and venom toxicology, using snakes as model systems. He teaches courses in zoology and herpetology, including Arizona fieldwork and advanced herpetology modules. Education: PhD in Systematics of Asian cobras from the University of Aberdeen (1990). His research interests include the evolution of venom composition, species delimitation in snake complexes, warning signals, biogeography, and conservation genomics. He supervises postgraduate students in topics like European viper conservation and snake systematics. Recent publications highlight his work on snake venoms, taxonomy, and the impacts of climate change on reptile species. He collaborates globally, contributing to antivenom efficacy studies and venom evolution research. Professor Wüster has been involved in projects such as genomic studies of adders and the phylogeography of vipers. His work bridges molecular ecology with conservation, emphasizing practical applications in biodiversity preservation.

Konstantinos Kalogeropoulosمشاهده پروفایل

استادیار

• Proteomics
• Snake Venom Research
• Protein Structure Prediction
• +۳ مورد دیگر

Konstantinos Kalogeropoulos is an Assistant Professor at the Department of Biotechnology and Biomedicine, Technical University of Denmark (DTU), leading research at the Cell Diversity Lab. His work bridges proteomics, computational biology, and snake venom research. Current projects: "The Proteomic Landscape during Influenza Infection" (2022-2025) Supervisor for PhD projects on protease network rewiring in psoriasis and wound exudate degradomics Research interests include: Proteomic analysis of inflammatory diseases Snake venom toxin structure prediction Extracellular matrix biomechanics De novo peptide sequencing algorithms Computational modeling of protease networks Recent article trends demonstrate his work in • Database-free proteomics (InstaNovo/InstaNexus) • Snake venom pathophysiology (V-ToCs clustering) • Inflammatory disease biomarkers (psoriasis, impaired healing) • Extracellular matrix mechanics (fibronectin tension, gut inflammation) Advising: Supervises PhD students Polhaus, C. J. M. and Haack, A. M., focusing on protease networks and wound healing.

Fernanda Cardosoمشاهده پروفایل

عضو هیئت علمی

• Venom peptide-based biodiscovery
• Therapeutics development for neurological disorders
• Ion channel modulators
• +۶ مورد دیگر

Dr Fernanda Cardoso is a Senior Research Fellow at the Institute for Molecular Bioscience, University of Queensland. She holds dual Brazilian-Australian citizenship and specializes in venom peptide-based biodiscovery and therapeutics development for neurological disorders such as chronic pain, motor neuron disease (MND), and irritable bowel syndrome (IBS). Her interdisciplinary expertise spans neuropharmacology, medicinal chemistry, and drug discovery. Education: Bachelor's, Universidade Federal de Minas Gerais (UFMG) MSc in Molecular Pharmacology, UFMG PhD in Biochemistry and Immunology, UFMG Research Interests: Mechanisms and therapies for chronic pain/visceral pain/IBS Neurodegeneration pathophysiology and drug development Venom pharmacology of spiders, cone snails, and snakes Structure-function relationships of venom peptides Voltage-gated ion channel modulation Grants & Projects: Current: Peptide Inhibitors Targeting Sodium Channels (2023-2026) Past: Multifunctional analgesic inhibitors (2020-2023), IBS pain therapies (2018-2019) Supervision: Recently advised 14 students on projects including ALS therapies, venom peptide characterization, and ion channel modulation. Current openings focus on venom bioactives and neurological disorder treatments. Achievements: Pioneered venom-based ion channel modulator discovery, identified neuroprotective venom peptides, and developed a schistosomiasis vaccine candidate. Her work bridges basic research with clinical applications for global health challenges.

Iekhsan Othmanمشاهده پروفایل

استاد

• Neurotoxicology
• Proteomics
• Venomics (Snake venom) and Anti-venomics
• +۳ مورد دیگر

Professor Iekhsan Othman is a renowned academic in biochemistry and neurotoxicology, currently serving as Professor and Deputy Head of School (Graduate Research) at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. He previously held leadership roles at the University of Malaya, including Head of the Department of Biochemistry and Deputy Dean. Education: Bachelor of Science (Hons) in Biochemistry, University of Bristol (1976–1979) PhD in Molecular Neurobiology, Imperial College London (1979–1983) Research focuses on neurotoxicology, natural products, cancer, and proteomics. He has published over 170 peer-reviewed articles and pioneered facilities like the Malaysian Proteomic Analysis Facilities (MAPAF) and the Agilent Integrated Biology Facility at Monash University. Awards include the Fulbright Scholarship, Chevening Malaysian Royal Society Award, and JSPS grants. Key contributions include advancing antivenom research, proteomic technologies, and neuroprotective agents. He is also involved in grants panels, editorial boards, and national initiatives like the Quality Management System (QMS) certification for medical faculties. Labs/Teams: Director of the Proteomics and Metabolomics platform and collaborator in the Venom and Toxin research group. Active in international collaborations, particularly in toxinology and cancer research.

Andrew Kingمشاهده پروفایل

استادیار

• Medical Toxicology
• Emergency Medicine
• Poison Control
• +۵ مورد دیگر

Andrew King is an Assistant Professor at Wayne State University School of Medicine and serves as Medical Toxicology Fellowship Director at Children’s Hospital of Michigan. He holds concurrent appointments as Medical Director of the Michigan Poison & Drug Information Center and Attending Physician at Sinai Grace Hospital, Detroit Receiving Hospital, and Children’s Hospital of Michigan. His clinical practice spans emergency medicine and toxicology. Education: M.D. from Washington University in St. Louis (2004-2008) B.A. from Northwestern University (2000-2004) Emergency Medicine Residency (Chief Resident) at University of Pittsburgh (2008-2011) Medical Toxicology Fellowship at University of Pittsburgh (2011-2013) Research Focus: Dr. King specializes in clinical toxicology with emphasis on poison control, envenomations, organophosphate poisoning, and cardiotoxicology. His work integrates emergency medicine protocols with toxicological interventions for substance overdoses, metabolic toxicities, and environmental exposures. Publication Trends: His 15 most recent articles (2012-2016) predominantly address toxicology case management, including innovative treatments for envenomations, antidotal therapies for poisonings, and diagnostic challenges in drug overdoses. Recurring themes include organophosphate/carbamate toxicity, sympathomimetic syndromes, and metal/chemical exposures. Awards & Honors: Distinguished Teacher of the Year (Sinai Grace/DRH Residency Programs, 2015) MTF Medical Toxicology Practice Award (2013) Resident Clinician of the Year (Pittsburgh, 2011) Alpha Omega Alpha Honor Society (2008) Professional Leadership: As Fellowship Director, he oversees toxicology training programs and advises medical fellows. He chairs committees for the American College of Medical Toxicologists (ACMT) and reviews manuscripts for multiple peer-reviewed journals including Journal of Medical Toxicology . Laboratories & Teams: Directs clinical operations at Michigan Poison & Drug Information Center, coordinating toxicology consultations and research collaborations across Detroit Medical Center hospitals.

• Veterinary Medicine
• Food Animal Production
• Parasitology
• +۳ مورد دیگر

John Gilliam is a Clinical Professor at Oklahoma State University's College of Veterinary Medicine since 2021, specializing in Food Animal Production Medicine and Field Service. Previously served as Clinical Associate Professor (2017-2021) and holds dual board certifications in Large Animal Internal Medicine-Food Animal (ACVIM) and Food Animal Practice (ABVP). DVM from Oklahoma State University (2001) His research focuses on bovine health , anthelmintic resistance , and snakebite treatment , with recent work on tetanus vaccination efficacy, parasite control in cattle, and translational porcine models for venom research. Publications span veterinary clinical trials, vaccine protocols, and toxicology studies. Teaching emphasizes livestock medicine and field service techniques , while service activities include extension lectures, conference presentations, and committee memberships in veterinary standards and curriculum development.

Pierre Lafayeمشاهده پروفایل

پژوهشگر

• Antibody Engineering
• Nanobodies (VHH)
• Immunotherapy
• +۱۳ مورد دیگر

Pierre Lafaye is the Head of the Antibody Engineering Platform at the Institut Pasteur, a leading institution in biological and medical research. His work is situated within the Technology Department, where he leads a core facility focused on the development and application of VHH (nanobody) technologies. The platform supports a wide range of academic and translational research projects, leveraging the unique properties of nanobodies such as small size, high stability, tissue penetration, and blood-brain barrier crossing ability. Research Interests: Dr. Lafaye’s research spans multiple domains, including cancer immunotherapy (e.g., targeting ILT4 as an immune checkpoint), neurodegenerative diseases (e.g., imaging Alzheimer’s plaques and tangles), infectious diseases (e.g., SARS-CoV-2 diagnostics and therapeutics), and antimicrobial resistance (e.g., targeting β-lactamases). His expertise lies in phage display, protein engineering, and in vivo molecular imaging. He has pioneered the use of dimeric VHHs for sensitive immunoassays and targeted diagnostics. Recent Publication Trends: His recent publications (2021–2024) reflect a strong emphasis on structural biology (using cryo-EM), viral entry mechanisms (especially coronaviruses), and the therapeutic and diagnostic application of nanobodies. Collaborative, high-impact studies in journals like Nature , Cell , and Nature Communications highlight his role in cutting-edge interdisciplinary research. Scientific Awards: While no specific awards are listed in the provided text, his leadership in IBiSA-certified core facilities and participation in major networks like EuroMabNet, Core For Life (CFL), and CTLS reflect recognition of his technical and scientific contributions. Advising and Grants: Dr. Lafaye has supervised multiple PhD students and postdoctoral researchers, indicating an active mentoring role. He leads several funded projects, including the ongoing CORONABODIES and Advances in Cancer Immunotherapy projects, as well as completed initiatives like ChagasDiag and VenoMATIcs. These projects involve collaborations across international Pasteur Institutes and academic partners. Labs and Teams: As head of the Antibody Engineering Platform, he oversees a multidisciplinary team comprising research engineers, technicians, postdocs, and PhD students. The facility is part of broader transversal initiatives at the Institut Pasteur, including those in brain connectivity, cancer, and emerging infectious diseases.

Rachel Allavenaمشاهده پروفایل

استاد

• Comparative and translational medicine
• Veterinary pathology
• Animal model validation
• +۷ مورد دیگر

Rachel Allavena is a Professor and Deputy Head of School at the School of Veterinary Science, The University of Queensland . She specializes in veterinary pathology and comparative medicine , developing cancer immunotherapies using pet dogs with natural cancer as models for human oncology. Her work bridges veterinary and human medicine, focusing on translational research . She also leads forensic pathology investigations for Racing Queensland , Queensland Police , and RSPCA Queensland , advocating for animal cruelty prevention . PhD in Comparative Medicine (Cornell University) Postgraduate Diploma in Veterinary Anatomic Pathology (University of Guelph) Bachelor of Veterinary Biology and Honours (University of Queensland) Her research spans comparative oncology (including canine brain cancer, lymphoma, melanoma, osteosarcoma ), koala conservation (co-developer of KoalaBASE database), and envenomation studies . She has trained ACVP board-certified pathologists and developed drug safety testing protocols in the UK pharmaceutical sector. Her immunotherapy trials have achieved 20% cure rates in terminal canine cancer patients. 2015 - Faculty of Science Teaching Excellence Award 2021 - UQ Citation for Outstanding Contributions to Student Learning As a media expert , she has featured in international outlets and delivered a TEDx talk on canine cancer therapy. She actively supervises PhD/MPhil students in projects like Canine Osteosarcoma Immunotherapy and Feline GI Lymphomas . Her team explores biometallic implants and forensic pathology applications.

• Clinical Toxicology
• Clinical Toxinology
• Emergency Medicine
• +۲ مورد دیگر

Geoffrey Isbister is a renowned Professor at the University of Newcastle , affiliated with the School of Medicine and Public Health . He leads the Clinical Toxicology Research Group and holds an NHMRC Senior Research Fellowship , focusing on venomous bites, drug overdoses, and acute behavioral disturbances. Education: Doctor of Medicine, University of New South Wales Bachelor of Medicine & Surgery, University of New South Wales Bachelor of Science, University of New South Wales Research Interests span three core areas: (1) Clinical Toxinology (Australian Snakebite Project, antivenom efficacy), (2) Pharmacokinetic modeling of drug overdoses (QT nomogram, ATOM study), and (3) Acute Behavioral Disturbance (sedation protocols). His work challenges conventional treatments and informs global guidelines. Recent publications address snakebite coagulopathy, antivenom timing, drug-induced QT prolongation, and GHB overdose trends. His studies in Clinical Toxicology and Lancet Global Health highlight innovations in point-of-care diagnostics and toxinology. Scientific Awards Member of the Order of Australia (2019) John Gilroy Potts Award (2015, 2014, 2013) Vice-Chancellor's Research Excellence Award (2013) Fellow of the European Association of Poison Centres (2014) His grants include NHMRC Program Grants and Senior Fellowships. Collaborations extend to Sri Lanka, Queensland, and international poison centers, emphasizing real-world applications of his research.

Wayne Hodgsonمشاهده پروفایل

استاد

• Pharmacology
• Venom Research
• Antivenom Development
• +۴ مورد دیگر

Wayne Hodgson is a Professor of Pharmacology and Deputy Dean (Education) in the Faculty of Medicine, Nursing and Health Sciences at Monash University. He holds dual roles in academic leadership and venom research, focusing on understanding venom biochemistry and improving health professions education. His educational background and qualifications are not explicitly listed, but his extensive contributions to academic administration and research suggest advanced training in Pharmacology and Health Sciences. Professional memberships or certifications are not detailed in the provided text. Research interests include venom pharmacology, antivenom efficacy evaluation, neurotoxicity mechanisms, myotoxicity analysis, and health professions selection processes. Specific projects involve: Molecular toxin evolution in venomous snakes Clinical applications of varespladib as a venom countermeasure Accreditation systems for health programs Rural healthcare workforce dynamics Comparative venom analysis across species His research trends emphasize interdisciplinary collaboration in venom studies and innovative educational frameworks. Key projects include leadership roles in Translational Venom and Antivenom Research (2016-2021) and Venom Evolutionary Mechanisms (2014-2016). No scientific awards are explicitly listed, but his research has received institutional support through NHMRC and ARC grants. He has contributed to over 214 publications, demonstrating significant academic output. As a researcher, he leads/co-leads 11 projects as Primary Chief Investigator (PCI) or Chief Investigator (CI). His work addresses venom-induced cardiovascular collapse, neurotoxin neutralization, and student selection tools in medical education. Collaborations span international institutions including Thailand, Sri Lanka, and Pakistan. He is involved in lab-based projects focused on venom characterization, antivenom testing, and pharmacokinetic analysis. Key lab activities include: Snake venom toxicity mechanisms in mammals Biosensor development for venom detection Long-term venom stability studies

Mehmet Zülfü YILDIZمشاهده پروفایل

استاد

• Herpetology
• Ecology
• Vertebrate Systematics
• +۵ مورد دیگر

Mehmet Zülfü YILDIZ is a Professor of Biology at Adıyaman University's Faculty of Arts and Sciences. He has held academic positions at Harran University and has served as an editorial board member or editor for journals including Kommagene Biology Journal , Biharean Biologist , and Acta Biologica Turcica . His research focuses on herpetology, ecology, and vertebrate systematics with emphasis on population dynamics, biodiversity conservation, and venom research. Received his BSc from Harran University in 2001 (top 3 rank) Completed MSc at Harran University in 2004 with thesis on antioxidant effects in experimental retinal ischemia Obtained PhD from Ege University in 2010 under Prof. Bayram Göçmen, focusing on population dynamics of a frog species Completed 8-month postdoctoral research at University of Kentucky in 2012 Recipient of the Uluslararası Yayın teşvik (International Publication Incentive) award His research interests span herpetofaunal biodiversity of Turkey, particularly in Eastern and Southeastern Anatolia regions. He investigates venom properties of Anatolian snakes, population genetics of threatened species, and ecological impacts of environmental factors such as microplastics. Major contributions include studies on Rana holtzi , Macrovipera lebetina , and Neurergus barani . Over 68 peer-reviewed articles and 34 completed projects reflect his work in Rana holtzi population studies, snake venom cytotoxicity, and biodiversity inventories. Notable projects include species action plans for endangered reptiles like the Van Lizard and Desert Varan , and ecological assessments for natural protected areas in southeastern Anatolia. He has advised numerous projects including the National Biodiversity Inventory and Monitoring Project for Ağrı and Van provinces, and served as principal investigator for venom research and conservation initiatives funded by institutions like TANAP and YÖK. Active in laboratory work involving vertebrate systematics and molecular phylogeny, he teaches courses on herpetology, ecology, and vertebrate anatomy at both undergraduate and graduate levels. His work combines field surveys with molecular techniques to advance conservation strategies for Turkey's unique herpetofauna.

• Cell Biology
• Biochemistry
• Cancer Biology
• +۳ مورد دیگر

Vania Braga is a Reader in Cell-cell Adhesion Signalling at Imperial College London’s National Heart & Lung Institute (NHLI), part of the Faculty of Medicine. She holds multiple leadership roles, including former Deputy Head of the Molecular Medicine Section (2012–2018) and Head of the Cardio-Respiratory Section (2018–2021). Her research focuses on epithelial signaling pathways, particularly E-cadherin-mediated adhesion and Rho/Rab GTPase regulation, with applications in cancer and disease mechanisms. Education includes a Biology degree from the Federal University of Minas Gerais (Brazil) and postdoctoral training at Imperial Cancer Research UK. Her work is funded by Cancer Research UK, MRC, and the Wellcome Trust. She supervises the CDT in Chemical Biology and participates in interdisciplinary networks like the Membrane Receptor Network and Vascular Science Network. Her research interests span junctional signaling, autophagy, and cell migration, with over 100 publications in top journals. She serves on editorial boards and frequently presents at international conferences (Gordon Conferences, FASEB). Recent work includes developing tools like Junction Mapper and studying snake venom cytotoxicity. Grants include Cancer Research UK (C1282/A11980), MRC (MR/J007668/1), and Wellcome Trust (GR081357MA). Awards include the MRC Non-Clinical Senior Fellowship (2012). She mentors students globally and leads outreach programs, emphasizing education and lab experience.

Esperanza Rivera de Torreمشاهده پروفایل

استادیار

• Antibody Engineering
• Venomics
• Antivenom Development
• +۷ مورد دیگر

Esperanza Rivera de Torre is an Assistant Professor at the Department of Biotechnology and Biomedicine, Technical University of Denmark. Her research focuses on antibody engineering, venomics, and protein design, particularly in neutralizing venom toxins and cancer therapy. Current affiliation: Department of Biotechnology and Biomedicine (DTU) Academic rank: Assistant Professor Research Interests Specializing in antibody engineering to develop synthetic antivenoms using de novo protein design. Investigating snake venom toxins and their neutralization mechanisms via VHH antibodies. Contributing to protemics and peptide sequencing through AI-driven tools like InstaNovo. Studying structural biology of actinoporins and their interactions with lipid membranes. Active in cross-neutralizing antibodies for tropical diseases and allergens. Advising and Collaborations Supervises multiple PhD students including Ruiz Espi, Møller, and Møiniche. Collaborates on projects like AI-driven protein binder design and allergen epitope characterization. Engages in international collaborations across venom and biomedical research fields.

Anne Ljungarsمشاهده پروفایل

پژوهشگر

• Antibody Technologies
• Antivenom Development
• Single-Domain Antibodies
• +۵ مورد دیگر

Anne Ljungars is a Senior Researcher at the Department of Biotechnology and Biomedicine, Technical University of Denmark , specializing in Antibody Technologies and Biologics Engineering . Her work focuses on advancing antivenom development, single-domain antibody engineering, and proteomics innovation. Expertise: Antivenom development, Phage display, Protein engineering, Toxin detection Key Projects: Supervising multiple PhD students in projects like AI-driven protein binder design and nanobody diagnostics Research trends are concentrated in snakebite envenoming , nanobody-based diagnostics , and computational proteomics . She contributes to UN Sustainable Development Goals via global health initiatives targeting neglected tropical diseases. Collaborations span immunology , toxicology , and biotechnology . Her recent publications emphasize single-domain antibodies , antibody-dependent enhancement , and high-throughput sequencing analysis .